Skip to main content

Table 1 Fasting blood glucose (mmol/L), and insulin (ng/ml) concentrations at the end of the trial

From: Mulberry leaf reduces inflammation and insulin resistance in type 2 diabetic mice by TLRs and insulin Signalling pathway

 

Dosage

0wk

2wk

4wk

6wk

8wk

10wk

insulin

NC mice

6.20 ± 0.31

7.10 ± 0.55

6.62 ± 0.54

5.35 ± 0.58

3.90 ± 0.40

3.85 ± 0.40

0.52 ± 0.13

Diabetic mice

22.13 ± 1.73**

21.67 ± 7.41*

20.87 ± 3.80

16.60 ± 1.98**

16.03 ± 1.90**

18.22 ± 2.37*

0.17 ± 0.00

WEM

2 g/kg

22.95 ± 1.73

11.22 ± 2.89

9.57 ± 0.65

8.57 ± 1.25##

6.47 ± 0.89#

9.23 ± 1.29

0.25 ± 0.02#

4 g/kg

21.95 ± 1.52

10.82 ± 3.25

11.70 ± 1.35

12.67 ± 1.88

6.87 ± 0.91#

9.43 ± 2.23

0.29 ± 0.03

8 g/kg

22.12 ± 2.15

10.35 ± 4.52

9.85 ± 0.71

8.65 ± 1.59##

5.98 ± 0.79#

5.28 ± 0.62#

0.33 ± 0.04

  1. Data are means ± SEM (n = 6).*P < 0.05, **P < 0.01, NC mice vs. Diabetic mice; #P < 0.05, ##P < 0.01, WEM vs. Diabetic mice. Fasting blood glucose (mmol/L) begins form 0wk from 10wk, and insulin (ng/ml) concentrations at the end of the trial is shown in the last column